荜铃胃痛颗粒联合盐酸伊托必利及艾司奥美拉唑治疗反流性食管炎的疗效观察-现代医学

荜铃胃痛颗粒联合盐酸伊托必利及艾司奥美拉唑治疗反流性食管炎的疗效观察

单位：南京中医药大学附属徐州市中医院消化内科, 江苏徐州 221000

分类号：R571

出版年·卷·期（页码）：2020·48·第一期（88-91）

摘要：

目的： 评价荜铃胃痛颗粒联合盐酸伊托必利及艾司奥美拉唑治疗反流性食管炎的临床疗效。方法： 选取反流性食管炎患者180例，采用随机、前瞻、自身对照分为A组（60例，荜铃胃痛颗粒+艾司奥美拉唑）、B组（60例，盐酸伊托必利+艾司奥美拉唑）、C组（60例，荜铃胃痛颗粒+盐酸伊托必利+艾司奥美拉唑），疗程均为8周。观察各组治疗前后患者临床症状改善情况。观察各组治疗前后内镜下食管黏膜炎症改善情况。方法： A、B、C组在临床症状方面的总有效率分别为80.00%（48/60）、76.67%（46/60）、93.33%（56/60），A组和C组比较、B组和C组比较，差异均有统计学意义（χ²=4.615、6.536，P均<0.05），A、B组间比较差异无统计学意义（χ²=0.196，P>0.05）。A、B、C组在内镜下食管黏膜炎症改善方面的总有效率分别为83.33%（50/60）、78.33%（47/60）、95.00%（57/60），A组和C组比较、B组和C组比较，差异均有统计学意义（χ²=4.227、7.212，P均<0.05），A、B组间比较差异无统计学意义（χ²=0.484，P>0.05）。方法： 荜铃胃痛颗粒和盐酸伊托必利两者联合艾司奥美拉唑均可缓解反流性食管炎患者的临床症状，改善内镜组织学，三者联合用药疗效更佳。

Objective: To evaluate the clinical efficacy of Biling Weitong Granule combined with itopride and esomeprazole in the treatment of reflux esophagitis. Methods: 180 patients with reflux esophagitis were randomly divided into group A (60 cases, Biling Weitong granule+esomeprazole), group B (60 cases, itopride+esomeprazole),group C (60 cases, Biling Weitong granule+itopride+eEsomeprazole). The course of treatment lasted 8 weeks. The improvement of clinical symptoms was observed before and after treatment. The improvement of endoscopic mucosal inflammation was observed before and after treatment. Results: The total effective rates of clinical symptoms in group A, B and C were 80.00% (48/60), 76.67% (46/60) and 93.33% (56/60), respectively. There were significant differences between group A and C, group B and group C (χ²=4.615、6.536,P<0.05). There was no significant difference between group A and B (χ²=0.196, P>0.05). The total effective rates of improving esophageal mucosal inflammation in group A, B and C were 83.33% (50/60), 78.33% (47/60) and 95.00% (57/60), respectively. There were significant differences between group A and C, as well as between group B and group C (χ²=4.227、7.212,P<0.05). There was no significant difference between group A and B (χ²=0.484, P>0.05). Conclusion: BilingWeitong granule combined with itopride and esomeprazole can alleviate the clinical symptoms of reflux esophagitis and improve endoscopic histology. The combination of the three drugs has a better curative effect.

参考文献：

[1] 游婷,王雯.胃食管反流病内镜治疗的研究进展[J].中华消化内镜杂志,2017,34(2):145-148.
[2] 牟宪臣.埃索美拉唑与奥美拉唑治疗反流性食管炎临床疗效对比分析[J].中外医疗,2015,12(19):106-107.
[3] 杜宪勇.伊托必利治疗功能性消化不良的疗效研究[J].中国医药指南,2017,15(27):183-184.
[4] 中华医学会消化病学分会.2014年中国胃食管反流病专家共识意见[J].中华消化杂志,2014,10(34):649-661.
[5] 潘红艳,向雪莲,吕尚泽,等.非糜烂性反流病与反流性食管炎症状特点的比较[J].中华内科杂志,2016,55(7):510-514.
[6] SIMONE V,SEBASTIANO B,ANGELA I,et al.Effects of transcranial direct current stimulation on esophageal motility in patients with gastroesophageal reflux disease[J].Clin Neurophysiol,2014,125(9):1840-1846.
[7] KATZ P O,GERSON L B,Vela M F.Corrigendum:guidelines for the diagnosis and management of gastroesophageal reflux disease[J].Am J Gastroenterol,2013,108(3):308-328.
[8] 赖苇,彭娥平,聂艳辉,等.埃索美拉唑联合枸橼酸莫沙必利治疗老年胃食管反流病的临床探讨[J].北方药学,2017,14(2):110-111.
[9] 黄伟泽.埃索美拉唑与奥美拉唑治疗反流性食管炎的临床效果对比[J].中国当代医药,2016,23(5):140-142.
[10] 李毅,梁巧林.埃索美拉唑和健胃愈疡片配合治疗反流性食管炎的效果讨论[J].中国现代药物应用,2016,10(02):153-154.
[11] 朱金照,黎环,吕勇,等.伊托必利对肝衰竭大鼠胃肠道动力的影响[J].中国现代医学杂志,2016,26(9):12-15.
[12] 王贤明.荜铃胃痛冲剂治疗十二指肠球部溃疡案例分析[J].世界最新医学信息文摘,2017,17(90):89.
[13] 冯显清,梁川,刘然.荜铃胃痛颗粒辅助治疗慢性胃炎的临床价值[J].中医中药,2017,15(12):108-109.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录